Latest California Healthline Stories
In this episode of KHN’s “What the Health?” Julie Rovner of Kaiser Health News, Margot Sanger-Katz of The New York Times, Joanne Kenen of Politico, and Erin Mershon of STAT News discuss a series of health policy court decisions on everything from prescription drug discounts to soda taxes. Plus, Rovner, interviews health care futurist and consultant Jeff Goldsmith.
The average increase in California is smaller than the double-digit hikes expected around the nation, due largely to a healthier mix of enrollees and more competition in its marketplace. Still, health insurance prices keep growing faster than wages and general inflation.
Daily nursing home payroll records just released by the federal government show the number of nurses and aides dips far below average on some days and consistently plummets on weekends. A new California law increases minimum staffing standards at nursing homes, but critics say it doesn’t go far enough.
Use this tool to see staffing levels at skilled nursing homes in California.
At least 70 infants have been ordered to appear in immigration court. Experts believe some were separated from their parents.
Some California children with serious health care problems wait more than a year for wheelchairs, bath benches, commodes, specialized crutches and other crucial medical equipment. Critics blame the delays on a confusing bureaucratic maze of private insurers and public programs.
A coalition of Republican states has launched a legal challenge to the Affordable Care Act, including provisions requiring insurers to offer coverage to people with preexisting conditions without raising rates. An analysis shows that some of these states have the highest proportion of such residents.
Some state Medicaid programs are not paying for the procedures, and Medicare’s complicated payment rates have hospitals concerned that it will not cover all the costs.
It’s getting increasingly difficult for patients to afford Truvada, also known as pre-exposure prophylaxis, or PrEP, because of the drug’s high price and insurance company efforts to restrict the use of coupons that shield patients from it.
A survey of 49 states reveals that an estimated 144,000 inmates with hepatitis C, a curable but potentially fatal disease, can’t get the expensive drugs they need to cure it. California lawmakers allocated $106 million in the state’s new budget to treat more infected prisoners.